Shay Capital LLC - MYMD PHARMACEUTICALS INC ownership

MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 36 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Shay Capital LLC ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$238,320
-34.7%
207,235
+48.0%
0.07%
-6.3%
Q3 2022$365,000
-45.6%
139,986
-54.7%
0.08%
-41.5%
Q2 2022$671,000
-55.2%
309,178
-3.7%
0.14%
-29.7%
Q1 2022$1,497,000
-31.0%
321,187
-10.2%
0.19%
-46.4%
Q4 2021$2,168,000
+52.7%
357,790
+81.4%
0.36%
+95.6%
Q3 2021$1,420,000
-59.9%
197,184
-64.9%
0.18%
-54.9%
Q2 2021$3,542,000562,2000.41%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Shay Capital LLC 139,986$365,0000.08%
Taylor & Morgan Wealth Management, LLC 17,086$45,0000.04%
Bridgecreek Investment Management, LLC 65,000$170,0000.04%
Corundum Group, Inc. 19,600$51,0000.03%
Aaron Wealth Advisors LLC 50,000$131,0000.02%
M Holdings Securities, Inc. 70,909$185,0000.02%
Cambria Investment Management, L.P. 65,398$171,0000.02%
Praetorian Wealth Management, Inc. 15,000$39,0000.02%
Mirae Asset Global Investments Co., Ltd. 638,580$1,667,0000.00%
Western Wealth Management, LLC 25,050$71,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders